AEDIFICA (AED.BR) Fundamental Analysis & Valuation

EBR:AED • BE0003851681

Current stock price

70.8 EUR
-0.75 (-1.05%)
Last:

This AED.BR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. AED.BR Profitability Analysis

1.1 Basic Checks

  • AED had positive earnings in the past year.
  • In the past year AED had a positive cash flow from operations.
  • AED had positive earnings in each of the past 5 years.
  • Each year in the past 5 years AED had a positive operating cash flow.
AED.BR Yearly Net Income VS EBIT VS OCF VS FCFAED.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

1.2 Ratios

  • With a Return On Assets value of 2.73%, AED perfoms like the industry average, outperforming 52.38% of the companies in the same industry.
  • AED has a Return On Equity (4.96%) which is comparable to the rest of the industry.
  • AED has a Return On Invested Capital of 3.52%. This is comparable to the rest of the industry: AED outperforms 52.38% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for AED is in line with the industry average of 3.84%.
  • The 3 year average ROIC (3.33%) for AED is below the current ROIC(3.52%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.73%
ROE 4.96%
ROIC 3.52%
ROA(3y)3.01%
ROA(5y)3.48%
ROE(3y)5.47%
ROE(5y)6.57%
ROIC(3y)3.33%
ROIC(5y)3.26%
AED.BR Yearly ROA, ROE, ROICAED.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

  • Looking at the Profit Margin, with a value of 49.82%, AED is in the better half of the industry, outperforming 61.90% of the companies in the same industry.
  • In the last couple of years the Profit Margin of AED has declined.
  • AED has a better Operating Margin (77.70%) than 71.43% of its industry peers.
  • In the last couple of years the Operating Margin of AED has remained more or less at the same level.
  • AED's Gross Margin of 97.93% is amongst the best of the industry. AED outperforms 97.62% of its industry peers.
  • AED's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 77.7%
PM (TTM) 49.82%
GM 97.93%
OM growth 3Y1.55%
OM growth 5Y0.91%
PM growth 3Y-20.75%
PM growth 5Y-10.29%
GM growth 3Y0.24%
GM growth 5Y0.4%
AED.BR Yearly Profit, Operating, Gross MarginsAED.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80 100

3

2. AED.BR Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AED is destroying value.
  • Compared to 1 year ago, AED has about the same amount of shares outstanding.
  • Compared to 5 years ago, AED has more shares outstanding
  • AED has a worse debt/assets ratio than last year.
AED.BR Yearly Shares OutstandingAED.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
AED.BR Yearly Total Debt VS Total AssetsAED.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

  • AED has an Altman-Z score of 1.40. This is a bad value and indicates that AED is not financially healthy and even has some risk of bankruptcy.
  • AED has a better Altman-Z score (1.40) than 92.86% of its industry peers.
  • AED has a debt to FCF ratio of 24.91. This is a negative value and a sign of low solvency as AED would need 24.91 years to pay back of all of its debts.
  • AED's Debt to FCF ratio of 24.91 is in line compared to the rest of the industry. AED outperforms 40.48% of its industry peers.
  • AED has a Debt/Equity ratio of 0.58. This is a neutral value indicating AED is somewhat dependend on debt financing.
  • AED has a Debt to Equity ratio of 0.58. This is in the better half of the industry: AED outperforms 69.05% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF 24.91
Altman-Z 1.4
ROIC/WACC0.52
WACC6.7%
AED.BR Yearly LT Debt VS Equity VS FCFAED.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

  • AED has a Current Ratio of 0.35. This is a bad value and indicates that AED is not financially healthy enough and could expect problems in meeting its short term obligations.
  • AED has a Current ratio of 0.35. This is comparable to the rest of the industry: AED outperforms 47.62% of its industry peers.
  • AED has a Quick Ratio of 0.35. This is a bad value and indicates that AED is not financially healthy enough and could expect problems in meeting its short term obligations.
  • AED's Quick ratio of 0.35 is in line compared to the rest of the industry. AED outperforms 52.38% of its industry peers.
Industry RankSector Rank
Current Ratio 0.35
Quick Ratio 0.35
AED.BR Yearly Current Assets VS Current LiabilitesAED.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

7

3. AED.BR Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 114.94% over the past year.
  • Measured over the past years, AED shows a decrease in Earnings Per Share. The EPS has been decreasing by -7.20% on average per year.
  • AED shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.06%.
  • AED shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 23.35% yearly.
EPS 1Y (TTM)114.94%
EPS 3Y-18.35%
EPS 5Y-7.2%
EPS Q2Q%180.79%
Revenue 1Y (TTM)8.06%
Revenue growth 3Y13.45%
Revenue growth 5Y23.35%
Sales Q2Q%6.32%

3.2 Future

  • The Earnings Per Share is expected to grow by 3.25% on average over the next years.
  • Based on estimates for the next years, AED will show a quite strong growth in Revenue. The Revenue will grow by 13.38% on average per year.
EPS Next Y4.51%
EPS Next 2Y3.64%
EPS Next 3Y3.55%
EPS Next 5Y3.25%
Revenue Next Year6.81%
Revenue Next 2Y14.48%
Revenue Next 3Y12.4%
Revenue Next 5Y13.38%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
AED.BR Yearly Revenue VS EstimatesAED.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M 500M
AED.BR Yearly EPS VS EstimatesAED.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3 4 5

3

4. AED.BR Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 14.78, AED is valued correctly.
  • AED's Price/Earnings is on the same level as the industry average.
  • When comparing the Price/Earnings ratio of AED to the average of the S&P500 Index (26.21), we can say AED is valued slightly cheaper.
  • With a Price/Forward Earnings ratio of 13.39, AED is valued correctly.
  • AED's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. AED is more expensive than 64.29% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 23.10, AED is valued a bit cheaper.
Industry RankSector Rank
PE 14.78
Fwd PE 13.39
AED.BR Price Earnings VS Forward Price EarningsAED.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • AED's Enterprise Value to EBITDA ratio is in line with the industry average.
  • AED's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. AED is more expensive than 69.05% of the companies in the same industry.
Industry RankSector Rank
P/FCF 57.02
EV/EBITDA 30.63
AED.BR Per share dataAED.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • The decent profitability rating of AED may justify a higher PE ratio.
PEG (NY)3.28
PEG (5Y)N/A
EPS Next 2Y3.64%
EPS Next 3Y3.55%

4

5. AED.BR Dividend Analysis

5.1 Amount

  • AED has a Yearly Dividend Yield of 4.10%, which is a nice return.
  • AED's Dividend Yield is slightly below the industry average, which is at 5.32.
  • Compared to an average S&P500 Dividend Yield of 1.89, AED pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.1%

5.2 History

  • On average, the dividend of AED grows each year by 22.82%, which is quite nice.
Dividend Growth(5Y)22.82%
Div Incr Years2
Div Non Decr Years2
AED.BR Yearly Dividends per shareAED.BR Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 2026 2 4 6

5.3 Sustainability

  • AED pays out 105.58% of its income as dividend. This is not a sustainable payout ratio.
  • The dividend of AED is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP105.58%
EPS Next 2Y3.64%
EPS Next 3Y3.55%
AED.BR Yearly Income VS Free CF VS DividendAED.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M
AED.BR Dividend Payout.AED.BR Dividend Payout, showing the Payout Ratio.AED.BR Dividend Payout.PayoutRetained Earnings

AED.BR Fundamentals: All Metrics, Ratios and Statistics

AEDIFICA

EBR:AED (4/7/2026, 7:00:00 PM)

70.8

-0.75 (-1.05%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-13
Earnings (Next)04-28
Inst Owners40.43%
Inst Owner ChangeN/A
Ins Owners0.11%
Ins Owner ChangeN/A
Market Cap5.91B
Revenue(TTM)358.28M
Net Income(TTM)175.81M
Analysts83.33
Price Target82.48 (16.5%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.1%
Yearly Dividend3.51
Dividend Growth(5Y)22.82%
DP105.58%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.89%
PT rev (3m)7.71%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0.95%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.14%
Valuation
Industry RankSector Rank
PE 14.78
Fwd PE 13.39
P/S 16.75
P/FCF 57.02
P/OCF 20.24
P/B 1.67
P/tB 1.71
EV/EBITDA 30.63
EPS(TTM)4.79
EY6.77%
EPS(NY)5.29
Fwd EY7.47%
FCF(TTM)1.24
FCFY1.75%
OCF(TTM)3.5
OCFY4.94%
SpS4.23
BVpS42.49
TBVpS41.44
PEG (NY)3.28
PEG (5Y)N/A
Graham Number67.67
Profitability
Industry RankSector Rank
ROA 2.73%
ROE 4.96%
ROCE 4.69%
ROIC 3.52%
ROICexc 3.55%
ROICexgc 3.61%
OM 77.7%
PM (TTM) 49.82%
GM 97.93%
FCFM 29.37%
ROA(3y)3.01%
ROA(5y)3.48%
ROE(3y)5.47%
ROE(5y)6.57%
ROIC(3y)3.33%
ROIC(5y)3.26%
ROICexc(3y)3.34%
ROICexc(5y)3.28%
ROICexgc(3y)3.4%
ROICexgc(5y)3.38%
ROCE(3y)4.43%
ROCE(5y)4.34%
ROICexgc growth 3Y6.29%
ROICexgc growth 5Y0.95%
ROICexc growth 3Y7%
ROICexc growth 5Y0.65%
OM growth 3Y1.55%
OM growth 5Y0.91%
PM growth 3Y-20.75%
PM growth 5Y-10.29%
GM growth 3Y0.24%
GM growth 5Y0.4%
F-Score7
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF 24.91
Debt/EBITDA 7.41
Cap/Depr 6078.86%
Cap/Sales 53.38%
Interest Coverage 250
Cash Conversion 105.31%
Profit Quality 58.95%
Current Ratio 0.35
Quick Ratio 0.35
Altman-Z 1.4
F-Score7
WACC6.7%
ROIC/WACC0.52
Cap/Depr(3y)11089%
Cap/Depr(5y)16628.2%
Cap/Sales(3y)126.51%
Cap/Sales(5y)150.79%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)114.94%
EPS 3Y-18.35%
EPS 5Y-7.2%
EPS Q2Q%180.79%
EPS Next Y4.51%
EPS Next 2Y3.64%
EPS Next 3Y3.55%
EPS Next 5Y3.25%
Revenue 1Y (TTM)8.06%
Revenue growth 3Y13.45%
Revenue growth 5Y23.35%
Sales Q2Q%6.32%
Revenue Next Year6.81%
Revenue Next 2Y14.48%
Revenue Next 3Y12.4%
Revenue Next 5Y13.38%
EBIT growth 1Y9.49%
EBIT growth 3Y15.21%
EBIT growth 5Y24.47%
EBIT Next Year10.93%
EBIT Next 3Y6.64%
EBIT Next 5Y11.79%
FCF growth 1Y142.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y18.63%
OCF growth 3Y7.82%
OCF growth 5Y22.86%

AEDIFICA / AED.BR Fundamental Analysis FAQ

What is the fundamental rating for AED stock?

ChartMill assigns a fundamental rating of 5 / 10 to AED.BR.


What is the valuation status of AEDIFICA (AED.BR) stock?

ChartMill assigns a valuation rating of 3 / 10 to AEDIFICA (AED.BR). This can be considered as Overvalued.


Can you provide the profitability details for AEDIFICA?

AEDIFICA (AED.BR) has a profitability rating of 6 / 10.


What is the earnings growth outlook for AEDIFICA?

The Earnings per Share (EPS) of AEDIFICA (AED.BR) is expected to grow by 4.51% in the next year.


Can you provide the dividend sustainability for AED stock?

The dividend rating of AEDIFICA (AED.BR) is 4 / 10 and the dividend payout ratio is 105.58%.